Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim
Daiichi Sankyo

Generated: February 21, 2018

DrugPatentWatch Database Preview

Drugs in MeSH Category Adrenergic alpha-2 Receptor Agonists

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms UsaGUANFACINE HYDROCHLORIDEguanfacine hydrochlorideTABLET, EXTENDED RELEASE;ORAL201382-001Jun 2, 2015ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
SuperpharmMETHYLDOPAmethyldopaTABLET;ORAL070669-001Jun 23, 1989DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Watson LabsGUANABENZ ACETATEguanabenz acetateTABLET;ORAL074025-002Feb 28, 1994DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Sun Pharm IndustriesMETHYLDOPAmethyldopaTABLET;ORAL070060-001Oct 9, 1986DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign Up
AvevaCLONIDINEclonidineFILM, EXTENDED RELEASE;TRANSDERMAL076157-001Aug 18, 2009ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
HospiraPRECEDEXdexmedetomidine hydrochlorideINJECTABLE;INJECTION021038-002Mar 13, 2013RXYesYes➤ Sign Up➤ Sign UpY➤ Sign Up
ShireINTUNIVguanfacine hydrochlorideTABLET, EXTENDED RELEASE;ORAL022037-002Sep 2, 2009ABRXYesNo➤ Sign Up➤ Sign Up➤ Sign Up
Mayne PharmaCLONIDINEclonidineFILM, EXTENDED RELEASE;TRANSDERMAL079090-001Aug 20, 2010ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
TevaMETHYLDOPAmethyldopaTABLET;ORAL071105-001Dec 5, 1986DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Sandoz IncDEXMEDETOMIDINE HYDROCHLORIDEdexmedetomidine hydrochlorideINJECTABLE;INJECTION091465-001Jun 14, 2016APRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: